TRACON Pharmaceutical (TCON) Tops Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to TRACON Pharmaceutical (TCON) Tops Q2 EPS by 6c

TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 10, 2022 4:02 PM EDT

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, today announced financial results for the second quarter ended June 30, 2022. The Company will host a conference call and webcast today at 4:30 PM Eastern Time / 1:30 PM Pacific Time.

We continue to have robust accrual in the ENVASARC pivotal trial as we have enrolled more than 36 patients and look forward... More